Problem
Bridging Knowledge Gaps in Rare Disease Treatment
Our client was on the verge of commercializing their first product across two rare disease indications. The brand was an entirely new way to treat patients—one that delivered efficacy without the trade-offs in tolerability. However, epigenetics was not a well-understood field, even among specialists. Appreciating the value of the brand necessitated a deeper understanding.
Approach
Strategic Medical Communication Platform to Simplify Epigenetic Science
To address these challenges, our team developed a cohesive approach to simplifying scientific communication and effectively convey the therapy’s benefits:
Creating a Lexicon
Working with our clients, we aligned on strategic language usage and choice to distill complex science into clear, consistent communication messaging
Label Optimization
With only a week to review the initial draft label, our team presented a series of specific evidence-based recommendations that were incorporated and accepted by the FDA
Disease-State Education
Our unbranded campaign created a new depth of disease understanding to establish the brand’s relevance
Communicating the Mechanism of Action
For each indication, we developed core visualizations that resonated with the treating specialist, telling the story clearly with just the right amount of detail
Results
Transforming Awareness and Adoption in Rare Disease Treatment
The strategic communication approach effectively bridged significant knowledge gaps, making complex scientific concepts clear and accessible. This initiative resulted in a deeper understanding and appreciation of the therapy’s unique benefits, driving its adoption and delivering remarkable results:
Rapid Adoption and Recognition
Launch promotion led to quick results in both awareness and early adoption
Widespread Usage
One in 12 patients were moved to this therapy within one month of launch
Increased Recognition
Within four months of launch, brand awareness was at 36%
Enhanced Disease Understanding
Targeted HCP education and visualizations paved the way for more effective diagnostic and treatment strategies
This case study highlights the transformative impact of a strategic communication platform in educating healthcare professionals and driving the adoption of innovative therapies. Our team offers guidance and support for professionals looking to apply these insights to enhance scientific communication, boost awareness, and achieve successful product launches. Complete the contact form below to get in touch with our experts.
Related Content
Optimizing Rare Disease Engagement for HCPs
A new medical Affairs model optimized HCP engagement, improving communication and supporting successful product launches.
Capabilities: Medical
Audiences: HCPs, Medical Affairs Teams
Clinical Trial Awareness Boost
An innovative strategy increased awareness and clinical trial participation, enhancing stakeholder relationships and trial success.
Capabilities: Medical
Audiences: HCPs, Medical Affairs Teams
First-in-Class Therapy Launch
An integrated digital strategy supported the successful launch of an innovative therapy. The approach elevated market access and stakeholder engagement.
Capabilities: Medical, Market Access, Activation Strategy, Brand Strategy, Creative
Audiences: HCPs, Patients, Payers
